Please login to the form below

Not currently logged in
Email:
Password:

Drug cure for breast cancer

Delegates at the European Breast Cancer Conference in Germany have seen new data revealing that Herceptin could prove an effective breast cancer cure
Delegates at the European Breast Cancer Conference (EBCC) in Germany have seen new data revealing that Herceptin could prove an effective breast cancer cure.

Herceptin (trastuzumab) has been developed for use in conjunction with chemotherapy prior to breast cancer surgery (neoadjuvant therapy). Results from the GeparQuatrro study, a randomised phase III trial, show that 45.5 per cent of female patients with HER2-positive breast cancer experienced complete tumour eradication.

Dr von Minckwitz of the University Women's Hospital in Frankfurt and managing director of German Breast Group, said: "Herceptin offers real hope for women with early breast cancer."

"Herceptin delivered on its promise of high tumour eradication when given to women with this aggressive form of breast cancer before their surgery," added Dr Minckwitz.

Over 1 million people are diagnosed with breast cancer worldwide with the disease claiming the lives of 400,000 patients annually.

According to Dr Untch, Helios Clinics in Berlin, "Herceptin makes women with this aggressive type of breast cancer feel more confident about their future".

HER2-positive breast cancer occurs in 20 to 30 per cent of all diagnosed cases. It is fast growing and is high likelihood of recurrence in patients. Herceptin is designed to target and block the function of HER2, a protein that has cancer causing potential.

18th April 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

Partnering with top global pharmaceutical companies, we push the boundaries to create meaningful, impactful and lasting learning opportunities. We leverage...

Latest intelligence

GDPR and events. What does the pharma industry need to know?
...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...

Infographics